Navigation Links
New Resource for Ophthalmology Clinical Trials: Strategic Alliance Announced.
Date:2/4/2013

Rochester, NY, USA (PRWEB) February 04, 2013

Ophthalmology has been shown to be one of the fastest growing fields of clinical research and this alliance aims to meet those needs by providing fast and accurate clinical trial results. The exemplary clinical quality and operational proficiency of Research Dynamics Consulting Group will complement the clinical knowledge and experience in Ophthalmology retained at ClinROC, LLC.

Lorraine D. Ellis, M.S., MBA, CEO/President said “ Working with ClinROC provides our clients with our operational efficiency and ophthalmology trial experience together with ClinROC’s extensive medical and clinical expertise.” The strategic partnership with Research Dynamics Consulting Group is the latest exciting development for ClinROC, LLC and concentrates on meeting the development needs of ophthalmic medical devices, pharmaceuticals and diagnostics. Dr Tara Vaz, Clinical Affairs and Co-Founder of ClinROC, LLC, said “This alliance allows our companies to conduct various designs and sizes of clinical trials to the highest quality standards, while providing the medical, clinical and scientific oversight to ensure the robustness of the outcomes.”

For over 20 years Research Dynamics has been providing CRO services specializing in the cost-efficient conduct and management of clinical research trials for the pharmaceutical, biologic, and medical device industries. Our services include project management, monitoring, auditing, site selection and management, EDC, data management and statistics, and other associated clinical development services. Although we work in all therapeutic areas, our expertise and focus are in many areas including ophthalmology as well as allergy, infectious diseases, neurology, oncology, respiratory, in-vitro diagnostics, and various medical devices. Research Dynamics is also known for its clinical research training programs. Research Dynamics provides the expertise and experience of large CROs with the flexibility and customization of a smaller organization.

ClinROC, LLC is a company of professionally qualified eye doctors with broad experience in Medical, Clinical and Scientific Affairs, including: clinical research, clinical trial conduct, R&D, clinical regulatory, medical writing and medical marketing. ClinROC, LLC is committed to offering perceptive and scientifically based solutions for eye care professionals and manufacturers of eye care products.

Media Contacts:
Contact Lorraine D. Ellis at Research Dynamics Consulting Group at 585-381-1350 x283 or find more information about the company at their website: http://www.resdyncg.com
Contact Dr Gerard Cairns at ClinROC, LLC at 585-203-7090 or find more information about the company at their website: http://www.clinroc.com.

Read the full story at http://www.prweb.com/releases/clinroc/clinicaltrial/prweb10388178.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
2. Palliative care resource helps ease changes
3. Markle releases new resources for health information sharing implementation
4. NOVAtime Solutions to be showcased at Booth #1821 in the upcoming Society for Human Resource Management (SHRM) Annual Conference and Exposition
5. New Anthropology and Archaeology Resources Published at Sciences Social Network
6. Natural Sciences Repository Publishes Chromatography and Acidic Compounds Resources
7. 'EMT Exam Ace' Creates Free EMT Resources Page
8. Podiatry Residents Advance Medical Training with New Online Resource
9. Protective bacteria in the infant gut have resourceful way of helping babies break down breast milk
10. Book offers resources for PTSD sufferers
11. New Online Resource Acts As Powerful Tool in the Battle against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Ron ... an option to senior, upper-level executives speaking at a business luncheon today, "It ... high-level executive is an asset to be fully realized and activated by the ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Renew Refresh Restore Reward”: is a ... Reward” is the creation of published author, Deborah Freeman, cofounded the Free Spirit Bible ... we returned to our cars, my sister-in-law invited us to come over before the ...
(Date:9/25/2017)... September 25, 2017 - Orlando, FL, Microsoft Ignite Conference (PRWEB) , ... ... ... Hosts, Inc . announced today that they have teamed up to deliver Netmail’s Hadron ... on-demand service from a HIPAA/HITRUST compliant Azure Cloud. Netmail will be demo-ing their Hadron ...
(Date:9/25/2017)... ... ... Ash Borers kill Ash trees in as little as 1-3 years. The signs ... by Rob Nagy, ISA Certified Arborist at Giroud Tree and Lawn, shows a street in ... signs of decline from Emerald Ash Borers, two Ash trees continue to thrive. ...
(Date:9/24/2017)... & Caicos Islands, BWI (PRWEB) , ... September 25, 2017 , ... ... to announce the resort is re-opening on October 1st. And, throughout the month ... three bedroom oceanfront rentals. , Hurricane Irma and Maria have passed and damage ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: